The Inflammasome Therapeutics Summit is a leading global conference dedicated to advances in inflammasome research and drug development. Shaperon’s participation and keynote presentation underscore ...
Advances in inflammasome biology are helping researchers address key selectivity and safety challenges in drug development.
LEHI, Utah, Nov. 10, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced six poster presentations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback